Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This is lame.
That's why I laugh at some of the people who don't understand how useless some this stuff can be.  The Arch conference won't be any different.  I've owned 2 stocks that attended it every year.  Both of the companies held promising futures.  The conference never produced any viable results.  The only way PTSC will make it long term is the good old fashion way, they will have to prove themselves.
Share
New Message
Please login to post a reply